Anfarm Hellas S.A. - Main Component
| Active Substance | Strength | Form |
|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
| Simvastatin | 20mg, 40mg | F.C.Tab |
| Somatostatin | 3mg/Vial | Ps.Sol.Inf |
| Suggamadex | 100mg/ml | Inj.Sol |
| TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf |
| Tenoxicam | 20mg/Vial | Ps.Inj.Sol |
| Tenoxicam | 20mg | F.C.Tab |
| Tigecycline | 50mg/Vial | Pd.Sol.Inf |
| Vancomycin | 500mg/Vial | Pd.Sol.Inf |
| Vancomycin | 1g/vial | Pd.Sol.Inf |
| Vildagliptin/MetforminUnder Development | (50+850)mg/tab & (50+1000)mg/tab | Tabs |
| Voriconazole | 200mg/Vial | Pd.Sol.Inf |
| Active Substance | Strength | Form |
|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
| Simvastatin | 20mg, 40mg | F.C.Tab |
| Somatostatin | 3mg/Vial | Ps.Sol.Inf |
| Suggamadex | 100mg/ml | Inj.Sol |
| TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf |
| Tenoxicam | 20mg/Vial | Ps.Inj.Sol |
| Tenoxicam | 20mg | F.C.Tab |
| Tigecycline | 50mg/Vial | Pd.Sol.Inf |
| Vancomycin | 500mg/Vial | Pd.Sol.Inf |
| Vancomycin | 1g/vial | Pd.Sol.Inf |
| Vildagliptin/MetforminUnder Development | (50+850)mg/tab & (50+1000)mg/tab | Tabs |
| Voriconazole | 200mg/Vial | Pd.Sol.Inf |
| Active Substance | Strength | Form | Market Availability |
|---|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol | International |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol | International |
| Simvastatin | 20mg, 40mg | F.C.Tab | Selected Markets |
| Somatostatin | 3mg/Vial | Ps.Sol.Inf | International |
| Suggamadex | 100mg/ml | Inj.Sol | International |
| TeicoplaninUnder Development | 200 mg & 400 mg/vial | Pd.Sol.Inf | Q1 2023 |
| Tenoxicam | 20mg/Vial | Ps.Inj.Sol | International |
| Tenoxicam | 20mg | F.C.Tab | Selected Markets |
| Tigecycline | 50mg/Vial | Pd.Sol.Inf | International |
| Vancomycin | 500mg/Vial | Pd.Sol.Inf | International |
| Vancomycin | 1g/vial | Pd.Sol.Inf | International |
| Vildagliptin/MetforminUnder Development | (50+850)mg/tab & (50+1000)mg/tab | Tabs | Q3 2021 |
| Voriconazole | 200mg/Vial | Pd.Sol.Inf | International |
